Your session is about to expire
← Back to Search
Relugolix + Itraconazole/Ritonavir for Prostate Cancer
Study Summary
This trial aims to understand the safety of combining drugs to treat advanced prostate cancer and reduce hormone production in testicles. It lasts up to 1 month.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have severe heart failure.I have a condition that affects how my gut absorbs nutrients.I am not currently on a trial drug or have not been within its active period.I need a specific combination therapy for my prostate cancer.I have prostate cancer confirmed by tests and will start hormone therapy.I am 18 years old or older.I am not taking medications that strongly interact with CYP3A4 and P-gp.I can take pills and will follow the medication schedule.I am allergic to medications similar to relugolix, itraconazole, or ritonavir.I am mostly self-sufficient and can carry out daily activities.I do not have any serious illnesses or situations that would stop me from following the study's requirements.
- Group 1: Study Group 2b
- Group 2: Study Group 3a
- Group 3: Study Group 3b
- Group 4: Study Group 1
- Group 5: Study Group 2a
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How hazardous is being part of Study Group 1 for individuals?
"Our evaluation team at Power gave Study Group 1 a score of 1 due to the limited amount of data available which attests to its safety and efficacy during Phase 1."
Is recruitment ongoing for this research project?
"Aye, the information being hosted on clinicaltrials.gov confirms that this medical experiment is still looking for participants to join their team. This research was first posted on February 13th 2023 and recently updated on February 21st of the same year. 100 patients are needed from one particular site."
How many individuals are partaking in this scientific exploration?
"Affirmative; the information on clinicaltrials.gov affirms that this medical experiment is currently recruiting participants. Initially posted on February 13th of 2023, with its last edit coming eight days later, it requires a hundred people to join at one location."
Share this study with friends
Copy Link
Messenger